SCHEMBL2312657

SCHEMBL2312657

OCCc1ccc2ccc3c(ccc4cccc(CCO)c43)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
HIF1A Q16665 1/20 0.38
ALDH1A1 P00352 2/20 0.36
THRB P10828 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALOX5 P09917 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
BACE1 P56817 1/20 0.36
BAD Q92934 2/20 0.35
ERBB2 P04626 1/20 0.34
FYN P06241 1/20 0.34
MAOA P21397 1/20 0.34
ACHE P22303 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2309775 0.92 KDM4E (0.39) CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9
SCHEMBL2310147 0.91 CYP1A2 (0.41) CYP1A2CYP2D6CYP2C19ALDH1A1THRB
SCHEMBL2310758 0.88 KDM4E (0.38) CYP1A2ALDH1A1KDM4EALOX5GAA
SCHEMBL2308581 0.86 CYP1A2 (0.42) CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9
SCHEMBL2307941 0.86 CYP1A2 (0.42) CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9
SCHEMBL2310354 0.85 CYP1A2 (0.43) CYP1A2CYP2D6CYP3A4ALDH1A1THRB
SCHEMBL2310086 0.84 CYP1A2 (0.50) CYP1A2CYP2C19CYP2C9ALDH1A1THRB
SCHEMBL2312805 0.83 CYP1A2 (0.42) CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9
SCHEMBL2311141 0.82 CYP1A2 (0.47) CYP1A2CYP3A4ALDH1A1THRBHPGD
SCHEMBL2310005 0.82 KDM4E (0.50) CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989517-B2 Actinic ray curable composition, actinic ray curable ink, and image formation process employing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-08-02 US disclosed
US-20070123600-A1 ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, AND IMAGE FORMATION PROCESS EMPLOYING THE SAME KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-31 US disclosed